Sofia, Bulgaria, October 13, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for significant shareholding from Ognian Donev.  As a result of exercising warrants from issue BG9200001212 and participation in the conditional capital increase, Ognian Donev crosses the threshold of 5% and increases his shareholding in the capital of the Company to 8.445%. 

Sofia, Bulgaria, October 6, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that as a result of the conditional capital increase through the exercise of warrants from an issue with ISIN BG9200001212 the new capital of "Sopharma" AD amounting to BGN 172,590,578 was entered in the Commercial Register, under number 20231006154857.